Lv11
20 积分 2023-09-10 加入
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
2小时前
已完结
Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: A real-world evidence study
8天前
已完结
Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agents in autoimmune diseases
8天前
已完结
Evaluating the causal effect of using glucagon-like peptide-1 receptor agonists on the risk of autoimmune diseases
8天前
已完结
皖公网安备34019202002308
